Ma Luo Selected Research

Ma Luo Research Topics

Disease

17	Infections 07/2021 - 04/2008
9	Inflammation (Inflammations) 03/2024 - 01/2019
7	Neoplasms (Cancer) 01/2021 - 02/2018
3	Breast Neoplasms (Breast Cancer) 11/2022 - 02/2018
3	HIV Infections (HIV Infection) 12/2020 - 01/2008
3	Viremia 10/2020 - 06/2015
2	Hepatocellular Carcinoma (Hepatoma) 03/2024 - 01/2021
2	Sexually Transmitted Diseases (Sexually Transmitted Disease) 04/2022 - 01/2008
2	Hypoxia (Hypoxemia) 01/2021 - 01/2019
2	Acquired Immunodeficiency Syndrome (AIDS) 01/2012 - 08/2010
2	Disease Progression 08/2010 - 10/2008
1	Adenocarcinoma 12/2023
1	Stomach Neoplasms (Stomach Cancer) 11/2023
1	Hepatitis 07/2022
1	HIV Seropositivity 04/2022
1	Vaginal Discharge 04/2022
1	Ulcer 04/2022
1	Nasopharyngeal Carcinoma 01/2021
1	Pancreatic Neoplasms (Pancreatic Cancer) 01/2021
1	Zika Virus Infection 10/2020
1	Ovarian Neoplasms (Ovarian Cancer) 03/2020
1	Critical Illness (Critically Ill) 01/2018
1	Rheumatoid Arthritis 12/2014
1	West Nile Fever 01/2011
1	Type 2 Diabetes Mellitus (MODY) 11/2010
1	Hyperglycemia 11/2010
1	Autoimmune Diseases (Autoimmune Disease) 10/2008
1	Parasitic Diseases (Parasitic Disease) 10/2008
1	Coinfection 01/2008
1	Vaccinia 11/2005

Drug/Important Bio-Agent (IBA)

6	Proteins (Proteins, Gene)FDA Link 04/2022 - 11/2010
5	VaccinesIBA 12/2020 - 01/2012
4	Messenger RNA (mRNA)IBA 03/2024 - 11/2012
4	HLA Antigens (Human Leukocyte Antigens)IBA 12/2014 - 04/2008
3	Peptides (Polypeptides)IBA 01/2020 - 10/2008
3	AntigensIBA 01/2018 - 10/2008
3	EpitopesIBA 01/2012 - 09/2009
2	CytokinesIBA 03/2024 - 01/2020
2	Interleukin-1 Receptors (Interleukin 1 Receptor)IBA 01/2022 - 01/2019
2	Oxygen (Dioxygen)IBA 01/2021 - 01/2019
2	Iodine-125IBA 01/2021 - 01/2021
2	ElementsIBA 05/2020 - 01/2020
2	AIDS VaccinesIBA 01/2020 - 01/2018
2	ImmunosorbentsIBA 05/2009 - 10/2008
2	EnzymesIBA 05/2009 - 10/2008
2	Interferon-gamma (Interferon, gamma)IBA 10/2008 - 11/2005
1	Interleukin-8 (Interleukin 8)IBA 03/2024
1	Interleukin-6 (Interleukin 6)IBA 03/2024
1	GlycosaminoglycansIBA 03/2024
1	Heparin (Liquaemin)FDA LinkGeneric 03/2024
1	Circular RNAIBA 03/2024
1	Tumor Biomarkers (Tumor Markers)IBA 07/2022
1	Staphylococcal Protein A (Protein A)IBA 01/2022
1	Protein Isoforms (Isoforms)IBA 07/2021
1	Biomarkers (Surrogate Marker)IBA 01/2021
1	gadolinium ethoxybenzyl DTPA FDA Link 01/2021
1	Codon (Codons)IBA 01/2021
1	Peptide Hydrolases (Proteases)FDA Link 12/2020
1	Antiviral Agents (Antivirals)IBA 10/2020
1	galidesivirIBA 10/2020
1	Complement System Proteins (Complement)IBA 05/2020
1	SAIDS VaccinesIBA 01/2020
1	NanovaccinesIBA 01/2020
1	ChemokinesIBA 01/2020
1	LipidsIBA 01/2019
1	FluorocarbonsIBA 01/2019
1	Dextrans (Dextran)FDA Link 01/2019
1	AntibodiesIBA 01/2018
1	Neutralizing AntibodiesIBA 01/2018
1	SIV(mac) proteinaseIBA 01/2018
1	RNA (Ribonucleic Acid)IBA 12/2016
1	Viral RNAIBA 12/2016
1	gag Gene Products (gag Protein)IBA 06/2015
1	Amino Acids FDA Link 12/2014
1	Monoclonal AntibodiesIBA 04/2014
1	Recombinant ProteinsIBA 04/2014
1	HLA-G Antigens (HLA G)IBA 01/2013
1	T-Lymphocyte Epitopes (Epitopes, T Lymphocyte)IBA 01/2012
1	LigandsIBA 01/2011
1	HLA-A Antigens (HLA-A)IBA 01/2011
1	Insulin (Novolin)FDA Link 11/2010
1	Glucose (Dextrose)FDA LinkGeneric 11/2010
1	Blood Proteins (Serum Proteins)IBA 11/2010
1	Dichlororibofuranosylbenzimidazole (DRB)IBA 05/2008
1	Histocompatibility Antigens Class IIIBA 05/2008
1	Immunologic Factors (Immunomodulators)IBA 01/2008

Therapy/Procedure

3	Segmental Mastectomy (Lumpectomy) 11/2022 - 02/2018
3	Brachytherapy 01/2021 - 04/2020
3	Radiotherapy 01/2021 - 02/2018
3	Therapeutics 02/2018 - 01/2008
2	Microbubbles 01/2021 - 01/2019
1	Gastrectomy 12/2023
1	Neoadjuvant Therapy 11/2023
1	Drug Therapy (Chemotherapy) 01/2021
1	Punctures 04/2020
1	Craniotomy 07/2019
1	Photochemotherapy (Photodynamic Therapy) 01/2019
1	Mastectomy (Mammectomy) 02/2018
1	Surgical Instruments (Clip) 02/2018